• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过血液滤过清除氨苄西林和庆大霉素。

Elimination of ampicillin and gentamicin by hemofiltration.

作者信息

Kraft D, Lode H

出版信息

Klin Wochenschr. 1979 Feb 15;57(4):195-6. doi: 10.1007/BF01477408.

DOI:10.1007/BF01477408
PMID:423486
Abstract

Elimination of ampicillin and gentamicin by hemofiltration was measured in 5 and 4 patients, respectively, being treated for end stage renal failure. Serum half-life time of ampicillin after a single I.V. dose of 2 g, was found to be 2.97 +/- 0.73 h, and the filtrate concentrations declined parallel to the serum ampicillin levels, as was to be expected. The serum half-life time after a single I.V. dose of 1 mg/kg body weight gentamicin was 3.26 +/- 0.42 h, and considerably shorter than T/2 of gentamicin in conventional hemodialysis, while the filtrate concentrations increased paradoxically with declining serum levels. This could be explained by binding of this aminoglycoside to the polyacrylnitril membrane of the RP 6 dialyser used for hemofiltration.

摘要

分别对5例和4例终末期肾衰竭患者进行血液滤过清除氨苄西林和庆大霉素的测定。单次静脉注射2g氨苄西林后,血清半衰期为2.97±0.73小时,滤过液浓度与血清氨苄西林水平平行下降,这是预期中的。单次静脉注射1mg/kg体重庆大霉素后的血清半衰期为3.26±0.42小时,明显短于传统血液透析中庆大霉素的半衰期,而滤过液浓度却随着血清水平下降而反常增加。这可以通过该氨基糖苷类药物与用于血液滤过的RP 6透析器的聚丙烯腈膜结合来解释。

相似文献

1
Elimination of ampicillin and gentamicin by hemofiltration.通过血液滤过清除氨苄西林和庆大霉素。
Klin Wochenschr. 1979 Feb 15;57(4):195-6. doi: 10.1007/BF01477408.
2
Drug elimination by hemofiltration.通过血液滤过进行药物清除。
J Dial. 1977;1(7):677-8. doi: 10.3109/08860227709037663.
3
Blood levels of ampicillin, kanamycin and gentamicin in the uremic patient.尿毒症患者体内氨苄青霉素、卡那霉素和庆大霉素的血药浓度
Isr J Med Sci. 1970 Nov-Dec;6(6):683-90.
4
Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.血液透析患者血清庆大霉素浓度的预测
Am J Hosp Pharm. 1980 Aug;37(8):1077-83.
5
[Pharmacokinetics of combined antibiotic therapy in the newborn infant].[新生儿联合抗生素治疗的药代动力学]
Monatsschr Kinderheilkd. 1983 Feb;131(2):58-62.
6
Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.间歇性血液透析中的氨基糖苷类药物:个体化给药的药代动力学
Ann Pharmacother. 2006 Jan;40(1):9-14. doi: 10.1345/aph.1G064. Epub 2005 Dec 6.
7
Time course of gentamicin serum concentration rebound following hemodialysis.血液透析后庆大霉素血清浓度反弹的时间进程。
Drug Intell Clin Pharm. 1987 Jan;21(1 Pt 1):46-9. doi: 10.1177/10600280870211p107.
8
Hemodialysis elimination rates and clearance of gentamicin and tobramycin.庆大霉素和妥布霉素的血液透析清除率及清除情况。
Antimicrob Agents Chemother. 1984 Jan;25(1):128-30. doi: 10.1128/AAC.25.1.128.
9
Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulfone membranes.
Am J Kidney Dis. 1999 Aug;34(2):222-7. doi: 10.1016/s0272-6386(99)70347-1.
10
Clearance of gentamicin during hemodialysis: comparison of four artificial kidneys.血液透析期间庆大霉素的清除率:四种人工肾的比较。
J Infect Dis. 1976 Jun;133(6):627-36. doi: 10.1093/infdis/133.6.627.

引用本文的文献

1
Treatment with echinocandins during continuous renal replacement therapy.持续肾脏替代治疗期间使用棘白菌素类药物治疗。
Crit Care. 2014 Mar 28;18(2):218. doi: 10.1186/cc13803.
2
In vitro adsorption of gentamicin and netilmicin by polyacrylonitrile and polyamide hemofiltration filters.聚丙稀腈和聚酰胺血液滤过器对庆大霉素和奈替米星的体外吸附。
Antimicrob Agents Chemother. 2010 Feb;54(2):963-5. doi: 10.1128/AAC.01215-09. Epub 2009 Nov 30.
3
Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.

本文引用的文献

1
[Ampicillin level in serum and urine in decreased kidney function].[肾功能减退时血清和尿液中的氨苄西林水平]
Dtsch Med Wochenschr. 1966 Feb 4;91(5):206-10. doi: 10.1055/s-0028-1110546.
2
Pharmacokinetics of gentamicin and kanamycin during hemodialysis.庆大霉素和卡那霉素在血液透析期间的药代动力学。
Antimicrob Agents Chemother. 1974 Dec;6(6):841-7. doi: 10.1128/AAC.6.6.841.
3
Kinetics of hemodiafiltration. II. Clinical characterization of a new blood cleansing modality.
J Lab Clin Med. 1975 Mar;85(3):372-91.
持续静脉-静脉血液滤过期间持续输注β-内酰胺类抗生素治疗耐药革兰阴性菌感染
Ann Pharmacother. 2009 Jul;43(7):1324-37. doi: 10.1345/aph.1L638. Epub 2009 Jul 7.
4
Adsorption of amikacin, a significant mechanism of elimination by hemofiltration.阿米卡星的吸附作用,这是血液滤过清除药物的一个重要机制。
Antimicrob Agents Chemother. 2008 Mar;52(3):1009-13. doi: 10.1128/AAC.00858-07. Epub 2007 Dec 17.
5
Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patients.间歇性血液透析和连续性肾脏替代治疗期间的药物剂量:儿科患者的特殊考量
Paediatr Drugs. 2004;6(1):45-65. doi: 10.2165/00148581-200406010-00004.
6
Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.持续肾脏替代治疗患者的药物剂量。药代动力学及治疗方面的考量。
Clin Pharmacokinet. 1993 May;24(5):362-79. doi: 10.2165/00003088-199324050-00002.
7
Multiple-dose pharmacokinetics of amikacin and ceftazidime in critically ill patients with septic multiple-organ failure during intermittent hemofiltration.阿米卡星和头孢他啶在脓毒症多器官功能衰竭危重症患者间歇性血液滤过期间的多剂量药代动力学
Antimicrob Agents Chemother. 1993 Mar;37(3):464-73. doi: 10.1128/AAC.37.3.464.
8
Clinical pharmacokinetics during continuous haemofiltration.持续血液滤过期间的临床药代动力学
Clin Pharmacokinet. 1994 Jun;26(6):457-71. doi: 10.2165/00003088-199426060-00004.
9
Pharmacokinetics of continuous renal replacement therapy.
Intensive Care Med. 1995 Jul;21(7):612-20. doi: 10.1007/BF01700172.
10
Drug removal by continuous arteriovenous haemofiltration. A review of the evidence in poisoned patients.持续动静脉血液滤过清除药物。中毒患者相关证据综述。
Med Toxicol Adverse Drug Exp. 1988 Sep-Oct;3(5):341-9. doi: 10.1007/BF03259889.
4
Binding of antibiotics by dialysis membranes and its clinical relevance.
Proc Eur Dial Transplant Assoc. 1977;14:607-9.